The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr1
start 173863900
end 173868882
lncRNA name GAS5
entrez id 60674
hgnc id HGNC:16355
ensg id ENSG00000234741
refseq id NR_002578
methods qPCR, RNAi etc.
regulated down-regulated
function description In this preclinical study, the consequences of decreased GAS5 expression for breast cancer cell survival following treatment with chemotherapeutic agents are addressed. GAS5 lncRNA promoted the apoptosis of triple-negative and oestrogen receptor-positive cells but only dual PI3K/mTOR inhibition was able to enhance GAS5 levels in all cell types. Reduced GAS5 expression attenuates apoptosis induction by classical chemotherapeutic agents in breast cancer cells, providing an explanation for the relationship between GAS5 expression and breast cancer patient prognosis.
pubmed id 24789445
year 2014
title Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy.
drug X
circulating X
survival V

CopyRight © University of Miami, USA; Harbin Medical University, China